We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+14.24%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$17.6B
AUM Growth
+$2.88B
Cap. Flow
+$1.8B
Cap. Flow %
10.23%
Top 10 Hldgs %
25.95%
Holding
2,706
New
730
Increased
658
Reduced
740
Closed
555

Sector Composition

Rank Sector Weight
1 Technology 14.11%
2 Industrials 11.26%
3 Healthcare 8.5%
4 Financials 8.16%
5 Consumer Discretionary 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRZ
1726
Amrize Ltd
AMRZ
$25.8B
$430K ﹤0.01%
8,868
-21,623
-71% -$1.1M
SIBN icon
1727
SI-BONE Inc
SIBN
$834M
$425K ﹤0.01%
28,866
-91,762
-76% -$1.5M
ATRC icon
1728
AtriCure
ATRC
$2.11B
$424K ﹤0.01%
+12,022
New +$414K
TMCI icon
1729
Treace Medical Concepts
TMCI
$309M
$423K ﹤0.01%
63,047
-239,156
-79% -$1.56M
LUMN icon
1730
Lumen
LUMN
$6.44B
$421K ﹤0.01%
+68,802
New +$330K
SLDB icon
1731
Solid Biosciences
SLDB
$826M
$420K ﹤0.01%
+68,002
New +$398K
FLNG icon
1732
FLEX LNG
FLNG
$1.67B
$419K ﹤0.01%
+16,641
New +$413K
DFTX
1733
Definium Therapeutics
DFTX
$6.12B
$419K ﹤0.01%
+35,510
New +$331K
VLRS
1734
Controladora Vuela Compania de Aviacion
VLRS
$939M
$418K ﹤0.01%
58,177
+32,596
+127% +$188K
HDRN
1735
Hadron Energy
HDRN
$123M
$417K ﹤0.01%
39,519
-25,481
-39% -$265K
FIVN icon
1736
FIVE9
FIVN
$2.6B
$417K ﹤0.01%
17,222
+2,429
+16% +$64.2K
KVUE icon
1737
CALL
Kenvue
KVUE
$36.9B
$415K ﹤0.01%
+25,600
New +$523K
KVUE icon
1738
PUT
Kenvue
KVUE
$36.9B
$415K ﹤0.01%
+25,600
New +$523K
NTWO
1739
Newbury Street II Acquisition Corp
NTWO
$414K ﹤0.01%
39,972
-13,310
-25% -$138K
EWT icon
1740
iShares MSCI Taiwan ETF
EWT
$10.7B
$413K ﹤0.01%
6,488
SVCC
1741
Stellar V Capital Corp
SVCC
$230M
$412K ﹤0.01%
40,000
-105,000
-72% -$1.08M
ARIS
1742
Aris Mining
ARIS
$3.59B
$406K ﹤0.01%
41,395
+5,004
+14% +$39.9K
COR icon
1743
Cencora
COR
$61.2B
$404K ﹤0.01%
1,293
+596
+86% +$175K
TVTX icon
1744
Travere Therapeutics
TVTX
$5.78B
$403K ﹤0.01%
16,872
-39,451
-70% -$742K
NVCR icon
1745
NovoCure
NVCR
$1.91B
$402K ﹤0.01%
+31,129
New +$416K
MYGN icon
1746
Myriad Genetics
MYGN
$312M
$401K ﹤0.01%
55,449
+21,834
+65% +$130K
YBIT
1747
YieldMax Bitcoin Option Income Strategy ETF
YBIT
$44.9M
$399K ﹤0.01%
+8,006
New +$414K
BLUW
1748
Blue Water Acquisition Corp III
BLUW
$335M
$399K ﹤0.01%
+40,000
New +$399K
CWK icon
1749
Cushman & Wakefield Ltd
CWK
$3.25B
$399K ﹤0.01%
+25,049
New +$353K
SFBS
1750
ServisFirst Bancshares
SFBS
$4.86B
$398K ﹤0.01%
4,945
+741
+18% +$61.4K

Similar funds

Schonfeld Strategic Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Schonfeld Strategic Advisors held 2,706 positions worth $17.6B, up 20% from $14.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Schonfeld Strategic Advisors deployed $1.8B of net new capital in Q3 2025, opening 730 new positions and adding to 658 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 202,655 shares worth $136M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Fidelity Wise Origin Bitcoin Fund, an estimated $247M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2025 buy was iShares Core S&P 500 ETF: 202,655 shares worth $136M.
  • Schonfeld Strategic Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $253M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2025 reduction was Fidelity Wise Origin Bitcoin Fund, cutting an estimated $247M.
  • Schonfeld Strategic Advisors fully exited Morgan Stanley in Q3 2025, selling an estimated $55.6M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 26% of its $17.6B portfolio in Q3 2025.
  • Schonfeld Strategic Advisors opened 730 new positions and closed 555 in Q3 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 20% quarter-over-quarter to $17.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.